WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William GuyerChief Development Officer2026-05-0520,000$51.83
$1.04MSell
William GuyerChief Development Officer2026-05-0520,000$21.65
$433.00kBuy
Joseph K. BelanoffChief Executive Officer2026-05-0140,000$50.10
$2.00MSell
William GuyerChief Development Officer2026-04-0720,000$21.65
$433.00kBuy
William GuyerChief Development Officer2026-04-0720,000$40.97
$819.40kSell
Joseph K. BelanoffChief Executive Officer2026-03-2526,198$50.07
$1.31MSell
William GuyerChief Development Officer2026-03-2011,767$36.01
$423.73kSell
William GuyerChief Development Officer2026-03-2011,767$21.65
$254.76kBuy
G. Leonard Baker Jr.Director2026-03-1724,218$33.56
$812.83kBuy
G. Leonard Baker Jr.Director2026-03-1775,782$33.00
$2.50MBuy

1 of 18

CORT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright41.73%44,802,403$2.67BInsider
Blackrock Inc11.32%12,151,276$725.31MInstitution
Bakker Juliet Tammenoms10.33%11,089,541$661.93MInsider
Longitude Venture Partners LP10.21%10,956,002$653.96MInsider
Alta Biopharma Partners II LP9.30%9,982,720$595.87MInsider
G. Leonard Baker Jr.8.79%9,440,067$563.48MInsider
Ingalls Snyder LLC7.09%7,608,716$454.16MInstitution
Tench Coxe6.42%6,890,503$411.29MInsider
Joseph C. Cook Jr.6.30%6,765,805$403.85MInsider
David L. Anderson5.98%6,420,729$383.25MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT28.92%71.08%Net BuyingNet Buying
SYRE76.30%23.70%Net SellingNet Selling
PTGX84.37%15.63%Net SellingNet Selling
APGE95.49%4.51%Net SellingNet Selling
KYMR78.23%21.77%Net BuyingNet Selling
View Top Biotech Stocks

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 73.78% institutional shareholders, 181.38% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 41.73% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $2.67B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.